Today's Hours: 8:00am - 8:00pm

Search

Did You Mean:

Search Results

  • Book
    Tommaso Scarabino, editor ; in collaboration with Ferdinando Caranci ... [and others].
    Summary: This atlas is a detailed guide to the imaging appearances of gliomas following treatment with neurosurgery, radiation therapy, and chemotherapy. Normal and pathological findings are displayed in detailed MR images that illustrate the potential modifications due to treatment. Particular emphasis is placed on characteristic appearances on the newer functional MR imaging techniques, including MR spectroscopy, diffusion-weighted imaging, and perfusion imaging. These techniques are revolutionizing neuroradiology by going beyond the demonstration of macroscopic alterations to the depiction of preceding metabolic changes at the cellular and subcellular level, thereby allowing earlier and more specific diagnosis. A key section comprising some 40 clinical cases and more than 500 illustrations offers an invaluable clinical and research tool not only for neuroradiologists but also for neurosurgeons, radiotherapists, and medical oncologists.

    Contents:
    Introduction
    Classification
    Gliomas
    Etiology
    Heredity
    Risk factors
    Pathogenesis
    Prognostic factors
    Complications
    Signs and symptoms
    Diagnosis and follow-up
    Supportive therapy
    Treatment of gliomas
    Surgery
    Radiotherapy
    Chemotherapy
    Post-treatment neuroradiological imaging.-Morphological magnetic resonance
    Functional magnetic resonance: Spectroscopy
    Diffusion
    Perfusion
    Cortical activation
    Clinical cases
    Bibliography.
    Digital Access Springer 2012
  • Article
    Adam A, Berson D, Levine C, Marchand P.
    S Afr Med J. 1977 Apr 23;51(17):594-6.
    A 20-year-old Coloured woman presented on three occasions with recurrent right-sided spontaneous pneumothorax which proved to be associated with pulmonary histiocytosis X. After corticosteroid therapy there was no recurrence of pneumothorax or radiographic evidence of progressive disease during a 6-month follow-up period.
    Digital Access Access Options